title: Is Statin Monotherapy the Perfect Polypill?
authors.affiliation: From Center for Cardiovascular Disease Prevention, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. pridker@partners.org.
authors.forename: Paul M
authors.initials: PM
authors.lastname: Ridker
mesh_terms: D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001562:Benzimidazoles / Q000008:administration & dosage / Q000627:therapeutic use; D001713:Biphenyl Compounds; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D050171:Dyslipidemias / Q000188:drug therapy; D006801:Humans; D006852:Hydrochlorothiazide / Q000008:administration & dosage / Q000627:therapeutic use; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D015337:Multicenter Studies as Topic; D012306:Risk; D000068718:Rosuvastatin Calcium / Q000008:administration & dosage / Q000627:therapeutic use; D013777:Tetrazoles / Q000008:administration & dosage / Q000627:therapeutic use
chemical_list: D000959:Antihypertensive Agents; D001562:Benzimidazoles; D001713:Biphenyl Compounds; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D013777:Tetrazoles; D006852:Hydrochlorothiazide; D000068718:Rosuvastatin Calcium; C081643:candesartan
keywords: atherosclerosis; drug prescriptions; pharmaceutical preparation; prevention; public policy; statin therapy; stroke